Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Chronic Infection”

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04111367
What this trial is testing

Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 2,3,6 Hepatitis C Virus Infection Patients

Who this might be right for
Hepatitis C Virus Infection
Ginkgopharma CO., LTD 36
Testing effectiveness (Phase 2)Study completedNCT00759200
What this trial is testing

Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients

Who this might be right for
Chronic Hepatitis C
Novartis 525
Not applicableStudy completedNCT02618928
What this trial is testing

The Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in France

Who this might be right for
Chronic Hepatitis C
AbbVie 735
Not applicableStudy completedNCT03200171
What this trial is testing

Effect of DAAs on Behavior of HCC in HCV Patients

Who this might be right for
Carcinoma, HepatocellularHepatitis C
Al-Azhar University 300
Testing effectiveness (Phase 2)Study completedNCT01058512
What this trial is testing

A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy

Who this might be right for
Hepatitis C
Cellectar Biosciences, Inc. 22
Testing effectiveness (Phase 2)Study completedNCT03485846
What this trial is testing

Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1b

Who this might be right for
Chronic Hepatitis C Genotype 1b
R-Pharm 105
Early research (Phase 1)Study completedNCT00828269
What this trial is testing

Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 12
Not applicableStudy completedNCT01054742
What this trial is testing

Observational Study of Patients With Chronic Hepatitis C Virus (HCV) Infected With HCV Genotype 1 Low Virus Load (LVL 1) and Effect of PegIntron Plus Rebetol Treatment (Study P04793 Part 2)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 2
Post-approval studies (Phase 4)Ended earlyNCT03797066
What this trial is testing

ATTIC - Access To Treat in the Community

Who this might be right for
Hepatitis C, Chronic
King's College Hospital NHS Trust 13
Testing effectiveness (Phase 2)Study completedNCT01628094
What this trial is testing

ANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based Treatment

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 110
Not applicableEnded earlyNCT01168856
What this trial is testing

An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 734
Testing effectiveness (Phase 2)Study completedNCT00704405
What this trial is testing

Safety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 285
Large-scale testing (Phase 3)Study completedNCT01343888
What this trial is testing

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 1)

Who this might be right for
Hepatitis C
Boehringer Ingelheim 656
Testing effectiveness (Phase 2)Study completedNCT01371578
What this trial is testing

Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 163
Post-approval studies (Phase 4)Ended earlyNCT04515797
What this trial is testing

QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir

Who this might be right for
Kidney FailureHepatitis CKidney Disease, Chronic
Massachusetts General Hospital 2
Large-scale testing (Phase 3)Study completedNCT00215891
What this trial is testing

PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon

Who this might be right for
Chronic Hepatitis C Infection in HIV-Infected PersonsHIV Infections
Hepatitis Resource Network 300
Post-approval studies (Phase 4)Study completedNCT00056862
What this trial is testing

Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3

Who this might be right for
Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 58
Testing effectiveness (Phase 2)Study completedNCT00763568
What this trial is testing

4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Romark Laboratories L.C. 40
Testing effectiveness (Phase 2)Study completedNCT05091008
What this trial is testing

Treatment of Chronic Hepatitis C Infection by Ledipasvir/Sofosbuvir in Naïve Children

Who this might be right for
Hepatitis C, Chronic
Mansoura University Children Hospital 50
Not applicableWithdrawnNCT01274013
What this trial is testing

Vitamin D Deficiency in Subjects With Chronic Hepatitis C Compared to Healthy Volunteers

Who this might be right for
Chronic Hepatitis C
Avera McKennan Hospital & University Health Center
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation